Superior mediastinal syndrome: emergency management

Area of Science:

• Pediatric Emergency Medicine
• Oncology
• Cardiorespiratory Medicine

Background:

• Superior Vena Cava Syndrome (SVCS) involves obstruction of the superior vena cava.
• Superior Mediastinal Syndrome (SMS) is diagnosed when SVCS coexists with tracheal obstruction.
• In children, mediastinal pathologies often cause both SVCS and SMS due to limited thoracic volume, leading to interchangeable use of terms.

Purpose of the Study:

• To outline the diagnosis, monitoring, and management of SMS in the pediatric emergency room setting.
• To highlight the high-risk nature of SMS and the potential for adverse cardiorespiratory events with anesthetic or sedative administration.
• To emphasize the importance of clinical condition guiding the urgency and sequence of investigations and treatment.

Main Methods:

• Review of common causes of SMS in pediatric emergency room presentations, including non-Hodgkin lymphoma and acute lymphoblastic leukemia.
• Emphasis on the preference for the least invasive procedures for diagnosis confirmation.
• Discussion of front-line therapy, often systemic steroids, particularly when lymphoma or leukemia is suspected.

Main Results:

• SMS is a medical emergency requiring careful management.
• Patients with SMS are at high risk for cardiorespiratory compromise if administered sedatives or anesthetics.
• Tissue diagnosis is desirable but not mandatory before initiating emergency management.

Conclusions:

• The clinical status of pediatric patients with SMS dictates the diagnostic and therapeutic approach.
• Systemic steroids are frequently the initial treatment for SMS in children due to common oncological causes.
• Effective management in the pediatric emergency room requires a balance between timely intervention and diagnostic confirmation.